Document Detail

Expression of liver fatty acid binding protein alters plasma membrane lipid composition and structure in transfected L-cell fibroblasts.
MedLine Citation:
PMID:  8431458     Owner:  NLM     Status:  MEDLINE    
Liver fatty acid binding protein, L-FABP, is an abundant protein that binds fatty acids in vitro. The effects of L-FABP on plasma membrane lipid composition, distribution, and physical structure were determined in intact L-cell fibroblasts transfected with cDNA encoding L-FABP. L-FABP expression altered plasma membrane phospholipids by decreasing both phosphatidylethanolamine and esterified oleic acid content, and increasing sphingomyelin. L-FABP also binds sterols and stimulates sterol uptake and esterification. The fluorescent sterol dehydroergosterol was used to examine sterol distribution in the transfected cell plasma membrane. Dehydroergosterol codistributed equally with the cholesterol in both the bulk membrane and the individual bilayer leaflets. The sterol/phospholipid ratio was decreased in the inner leaflet due to sterol depletion. Concomitantly, intermembrane sterol transfer from the rapidly exchangeable lateral sterol domains as measured by exchange of dehydroergosterol, was reduced. The fluidity of the plasma membrane was measured with the fluorescent molecule diphenylhexatriene by multifrequency (1-250 MHz) phase and modulation fluorometry. Both the bulk plasma membrane and the plasma membrane outer leaflet lipids were fluidized in transfected cells. These alterations of plasma membrane structure and composition are consistent with a role for L-FABP in regulating intracellular sterol and fatty acid distribution and thereby membrane lipid domain structure.
J K Woodford; J R Jefferson; W G Wood; T Hubbell; F Schroeder
Related Documents :
19285478 - Liver type fatty acid binding protein (l-fabp) gene ablation reduces nuclear ligand dis...
5016298 - Stages of uptake and incorporation of micellar palmitic acid by hamster proximal intest...
10331658 - Cytochrome p450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein c...
9392528 - Effect of genetic variation on the fatty acid-binding properties of human serum albumin...
9294168 - Engineering a trna and aminoacyl-trna synthetase for the site-specific incorporation of...
667748 - The syndrome of carnitine deficiency: morphological and metabolic correlations in two c...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Biochimica et biophysica acta     Volume:  1145     ISSN:  0006-3002     ISO Abbreviation:  Biochim. Biophys. Acta     Publication Date:  1993 Feb 
Date Detail:
Created Date:  1993-03-17     Completed Date:  1993-03-17     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0217513     Medline TA:  Biochim Biophys Acta     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  257-65     Citation Subset:  IM    
Department of Pharmacology and Cell Biophysics, University of Cincinnati, OH 45267-0004.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carrier Proteins / metabolism*
Fatty Acid-Binding Proteins
L Cells (Cell Line) / metabolism
Liver / metabolism*
Membrane Fluidity
Membrane Lipids / chemistry*,  metabolism
Molecular Structure
Neoplasm Proteins*
Nerve Tissue Proteins*
Oleic Acid
Oleic Acids / analysis
Phosphatidylethanolamines / analysis
Phospholipids / chemistry*,  metabolism
Grant Support
Reg. No./Substance:
0/Carrier Proteins; 0/Fabp1 protein, mouse; 0/Fabp5 protein, mouse; 0/Fabp7 protein, mouse; 0/Fatty Acid-Binding Proteins; 0/Membrane Lipids; 0/Neoplasm Proteins; 0/Nerve Tissue Proteins; 0/Oleic Acids; 0/Phosphatidylethanolamines; 0/Phospholipids; 112-80-1/Oleic Acid; 1720-32-7/Diphenylhexatriene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Solubilization and functional reconstitution of the human placental taurine transporter.
Next Document:  Amiloride and 5-(N-ethyl-N-isopropyl) amiloride inhibit medium acidification and glucose metabolism ...